| Rutgers Cancer Institute

Ganesan Army Breakthrough Award Feb 2021

$1.33 Million Award Supports Research to Better Inform HER2 Breast Cancer Treatment

A Rutgers Cancer Institute collaboration with George Mason University received the U.S. Army’s Breast Cancer Research Program Breakthrough Award to quickly confirm if an identified HER2 biomarker can indicate success likelihood of personalized treatments. Read more

Read more about Ganesan Army Breakthrough Award Feb 2021

Mason Scientists and Rutgers Cancer Institute Collaboration Receives U.S. Army’s Breakthrough Award to Better Inform HER2 Breast Cancer Treatment

Cancer Metabolism

*/ /*-->*/ /*-->*/

Breaking Through the Latest Breakthroughs.

Read more about Cancer Metabolism

Good Manufacturing Practices (GMP)

*/ /*-->*/ /*-->*/

In-House Technology.

Read more about Good Manufacturing Practices (GMP)

Cell Therapy

*/ /*-->*/ /*-->*/ /*-->*/

Further Advancing the Latest Technology.

Read more about Cell Therapy

Immune Checkpoint Blockade

*/ /*-->*/ /*-->*/ /*-->*/

How does cancer “work?”

Read more about Immune Checkpoint Blockade

Exploring Impact of Surgery Delays for Clinical Renal Cell Carcinoma Patients during the COVID-19 Pandemic

Center of Excellence in Cancer Immunology and Metabolism Membership

*/

Read more about Center of Excellence in Cancer Immunology and Metabolism Membership

Gallbladder and Bile Ducts: Small Organs with Big Responsibilities

50th Anniversary of the National Cancer Act

*/ /*-->*/ /*-->*/ /*-->*/

Why Commemorate 50 Years of the National Cancer Act?

Read more about 50th Anniversary of the National Cancer Act